The acquisition will enable Prism, an ophthalmology and retina management company with 180 providers, 91 office locations, and seven ASCs, to enhance its focus on data analytics, clinical research investments, and biopharma partnerships, according to a Feb. 4 news release from McKesson.
Prism Vision physicians will retain a 20% ownership stake in the company. Pending regulatory approval, Prism will be integrated into McKesson’s U.S. Pharmaceutical segment.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.